India Pharma Outlook Team | Thursday, 16 October 2025
Aragen, a prominent global contract research, development, and manufacturing organization (CRDMO), has announced the appointment of Neeraj Garg as Chief Executive Officer of its Discovery Solutions division.
In this capacity, Neeraj will lead strategic initiatives aimed at driving sustainable and profitable growth through both organic development and strategic acquisitions.
His responsibilities will also include broadening the company’s client network, enhancing operational effectiveness, and fostering new capabilities to support and accelerate the research efforts of Aragen’s partners.
Also Read: Supriya Lifescience Receives State Award for Export Leadership
He will operate out of the company’s corporate headquarters in Hyderabad and will serve as a member of Aragen’s Management Council. Manni Kantipudi, MD & CEO, Aragen Life Sciences said, “Neeraj’s appointment comes at an exciting time in Aragen’s growth journey,” said “We have built a strong legacy in pioneering discovery research. With his extensive leadership experience across the life sciences, pharmaceuticals, and consumer sectors, Neeraj is ideally suited to lead us into our next phase of growth.”
Commenting on his appointment, Neeraj Garg said, “Aragen has built a tremendous pedigree as a global CRDMO leader and, during the last few years, it has formed strategic partnerships with increasing number of global pharmaceutical ; so I am joining at a pivotal stage for the company. I look forward to working with our talented teams to deliver exceptional value to our customers, accelerate scientific breakthroughs, and drive translational research that will help discover the medicines of tomorrow.”
